114 related articles for article (PubMed ID: 2560627)
1. Relationship of the 1 alpha, 25-dihydroxyvitamin D3 receptor concentration and the DNA content in renal cell carcinomas.
Trydal T; Bakke A; Aksnes L; Aarskog D
Anticancer Res; 1989; 9(6):1951-5. PubMed ID: 2560627
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue.
Trydal T; Bakke A; Aksnes L; Aarskog D
Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346
[TBL] [Abstract][Full Text] [Related]
3. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric analysis of renal cell carcinoma].
Lü GH
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometry of DNA in research on kidney tumors].
Zubrikhina GN; Sokolova IN; Chistiakova OV
Arkh Patol; 1989; 51(8):16-20. PubMed ID: 2554862
[TBL] [Abstract][Full Text] [Related]
6. Tumor spread and DNA content in human renal cell carcinoma.
Ljungberg B; Stenling R; Roos G
Cancer Res; 1988 Jun; 48(11):3165-7. PubMed ID: 3365699
[TBL] [Abstract][Full Text] [Related]
7. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
Nagakura K
Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
[No Abstract] [Full Text] [Related]
8. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
[TBL] [Abstract][Full Text] [Related]
9. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.
Veloso JD; Solis OG; Barada JH; Fisher HA; Ross JS
Arch Pathol Lab Med; 1992 Feb; 116(2):154-8. PubMed ID: 1733409
[TBL] [Abstract][Full Text] [Related]
12. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
13. In vivo aneuploidization during the expansion of renal adenocarcinoma.
Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
el-Naggar AK; Pathak S
Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma.
Danova M; Giordano M; Torelli F; Franchini G; Cappellano F; Riccardi A; Catanzaro F; Mazzini G
Eur J Histochem; 1992; 36(3):279-88. PubMed ID: 1281010
[TBL] [Abstract][Full Text] [Related]
18. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 receptors in human carcinomas: a pilot study.
Sandgren M; Danforth L; Plasse TF; DeLuca HF
Cancer Res; 1991 Apr; 51(8):2021-4. PubMed ID: 1849039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
